JP2023546725A5 - - Google Patents
Info
- Publication number
- JP2023546725A5 JP2023546725A5 JP2023525078A JP2023525078A JP2023546725A5 JP 2023546725 A5 JP2023546725 A5 JP 2023546725A5 JP 2023525078 A JP2023525078 A JP 2023525078A JP 2023525078 A JP2023525078 A JP 2023525078A JP 2023546725 A5 JP2023546725 A5 JP 2023546725A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- amino acid
- domain
- cells
- chimeric protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105744P | 2020-10-26 | 2020-10-26 | |
| US63/105,744 | 2020-10-26 | ||
| PCT/US2021/027294 WO2022093310A1 (en) | 2020-10-26 | 2021-04-14 | Homodimeric and heterodimeric proteins comprising butyrophilin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546725A JP2023546725A (ja) | 2023-11-07 |
| JP2023546725A5 true JP2023546725A5 (https=) | 2024-04-24 |
Family
ID=81384237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525078A Pending JP2023546725A (ja) | 2020-10-26 | 2021-04-14 | ブチロフィリンを含むホモ二量体及びヘテロ二量体タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230416333A1 (https=) |
| EP (1) | EP4232065A4 (https=) |
| JP (1) | JP2023546725A (https=) |
| CN (1) | CN116801897A (https=) |
| AU (1) | AU2021370788A1 (https=) |
| CA (1) | CA3196533A1 (https=) |
| WO (1) | WO2022093310A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022238339A1 (en) * | 2021-03-16 | 2023-10-26 | Shattuck Labs, Inc. | Gamma delta t-cell costimulation |
| US20250179144A1 (en) * | 2021-12-09 | 2025-06-05 | The University Of Melbourne | Modified Butyrophilin and Butyrophilin Complexes |
| WO2024006889A2 (en) * | 2022-06-29 | 2024-01-04 | Shattuck Labs, Inc. | Cd20-targeted gamma delta t cell modulation |
| WO2024006907A2 (en) * | 2022-06-29 | 2024-01-04 | Shattuck Labs, Inc. | B7h3-targeted gamma delta t cell modulation |
| CN118290582A (zh) * | 2022-06-30 | 2024-07-05 | 深圳市乐土生物医药有限公司 | 抗人Claudin18.2抗体及其应用 |
| WO2024123812A1 (en) | 2022-12-05 | 2024-06-13 | Shattuck Labs, Inc. | Fusion proteins for the treatment of cardiometabolic diseases |
| WO2025007059A1 (en) * | 2023-06-30 | 2025-01-02 | Myeloid Therapeutics, Inc. | Engineered chimeric fusion protein compositions and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6981973B2 (ja) * | 2015-10-01 | 2021-12-17 | ヒート バイオロジクス，インコーポレイテッド | Ｉ型及びｉｉ型細胞外ドメインを異種キメラタンパク質として連結する組成物及び方法 |
| WO2020047329A1 (en) * | 2018-08-29 | 2020-03-05 | Shattuck Labs, Inc. | Chimeric proteins comprising extracellular domains and uses thereof |
| PH12021551475A1 (en) * | 2019-01-07 | 2022-05-02 | Shattuck Labs Inc | Heterodimeric proteins for modulating gamma delta t cells |
| US11098093B2 (en) * | 2019-01-07 | 2021-08-24 | Shattuck Labs, Inc. | Heterodimeric proteins for modulating gamma delta T cells |
-
2021
- 2021-04-14 JP JP2023525078A patent/JP2023546725A/ja active Pending
- 2021-04-14 CA CA3196533A patent/CA3196533A1/en active Pending
- 2021-04-14 US US18/033,403 patent/US20230416333A1/en active Pending
- 2021-04-14 WO PCT/US2021/027294 patent/WO2022093310A1/en not_active Ceased
- 2021-04-14 EP EP21887084.8A patent/EP4232065A4/en not_active Withdrawn
- 2021-04-14 CN CN202180087304.4A patent/CN116801897A/zh active Pending
- 2021-04-14 AU AU2021370788A patent/AU2021370788A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023546725A5 (https=) | ||
| Jin et al. | Emerging new therapeutic antibody derivatives for cancer treatment | |
| JP2024059628A (ja) | Ｃｄ１９指向性キメラ抗原受容体および免疫療法におけるその使用 | |
| JP2020530299A5 (https=) | ||
| JP2024500847A5 (https=) | ||
| JP2019523630A5 (https=) | ||
| JP2020530298A5 (https=) | ||
| JP2020506727A5 (https=) | ||
| CN114072427A (zh) | 抗dll3嵌合抗原受体及其用途 | |
| CN107636015A (zh) | 包含结合蛋白和对IL‑15Rα具有降低亲和力的白介素‑15多肽的融合蛋白及其治疗用途 | |
| RU2018139339A (ru) | Новые биспецифические полипептиды против cd137 | |
| JP2020530989A5 (https=) | ||
| JP2018046811A (ja) | 異常細胞を標的とする多重特異性結合分子 | |
| WO2018177371A1 (en) | Antigen-specific t cells and uses thereof | |
| US20230028399A1 (en) | Bcma-directed cellular immunotherapy compositions and methods | |
| JP2022516964A5 (https=) | ||
| JP2022549186A5 (https=) | ||
| WO2018119118A4 (en) | Lymphotoxin-beta receptor-binding agents, targeting antibodies, and uses thereof | |
| JP2024519335A (ja) | がん免疫療法のための投薬レジメン | |
| CN115698088A (zh) | 免疫细胞衔接器多特异性结合蛋白及其制备和应用 | |
| JP2024525727A5 (https=) | ||
| JP2024543043A5 (https=) | ||
| JP2019505545A5 (https=) | ||
| WO2024078479A1 (zh) | 一种异源二聚体融合蛋白及其应用 | |
| JP2023534959A5 (https=) |